Everolimus in HR-positive advanced breast cancer

N Engl J Med. 2012 May 3;366(18):1739; author reply 1739-40. doi: 10.1056/NEJMc1202719.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androstadienes / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Sirolimus / analogs & derivatives*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Androstadienes
  • Aromatase Inhibitors
  • TOR Serine-Threonine Kinases
  • Sirolimus